top of page
Mount Heart Regeneration Hero.png

Reawakening the heart’s ability to heal.

We’re developing small-molecule metabolic therapies to unlock the adult heart’s regenerative potential after injury.

Why regeneration matters.

After a heart attack, injured heart muscle is replaced by scar tissue. We are exploring a different path: helping the adult heart activate its own regenerative processes.

​

Metabolic reprogramming.

​A new direction in heart regeneration.

Our approach targets succinate dehydrogenase (SDH) to reprogram cardiac metabolism. Preclinical research links this metabolic shift with heart-muscle renewal, new blood-vessel formation, and reduced fibrosis.

​

​Mount Therapeutics is translating these discoveries into regenerative medicines, beginning with our lead program, MTX-101.

MTX-101.

​Our lead program.

PREPARING FOR IND-ENABLING STUDIES

​

MTX-101 is our first-in-class small-molecule candidate, being developed as an injectable therapy for cardiac regeneration following myocardial infarction.

​

The program targets succinate dehydrogenase (SDH) to shift cardiac metabolism and activate regenerative processes. Preclinical studies demonstrated heart-muscle renewal, revascularization, and reduced fibrosis.

​

​Our goal: translate this biology into a regenerative therapeutic for people recovering from a heart attack.

Built on discovery.

​Grounded in evidence.

FOUNDATIONAL RESEARCH

​

Our approach builds on research into the metabolic signals that govern cardiac regeneration.

​

A foundational study published in Circulation in 2021 demonstrated the therapeutic potential of metabolic reprogramming, resulting in adult cardiomyocyte proliferation, and heart regeneration.

​

​This work helped establish the scientific rationale for exploring SDH inhibition as a regenerative strategy. Our publications provide the detail behind the approach.

The next chapter.

​Let’s build it together.

PARTNER WITH MOUNT

​

Moving a discovery toward patients takes shared expertise and a common purpose.

​

We welcome conversations with scientific collaborators and development partners who share our ambition to advance regenerative therapies for the injured heart.

​

​Explore the science. Meet our team. Start a conversation.

© 2026 Mount Therapeutics, Inc. · La Jolla, California

© 2026 Mount Therapeutics, Inc. · La Jolla, California

bottom of page